[1]
2022. Can the exacerbated synthesis of inflammatory markers in COVID-19 impair the response to treatments in patients with coronavirus?. Research, Society and Development. 11, 11 (Aug. 2022), e337111133562. DOI:https://doi.org/10.33448/rsd-v11i11.33562.